
25/05/2025
Honored to have been invited as a Faculty speaker at the Indian Medical Association (IMA) to discuss **Advanced Management of Stage 4 Stomach Cancers & the Role of Robotic Surgery in stomach Cancer”**
It was a privilege to share insights on:
🔹 **Cutting-edge systemic therapies** (immunotherapy, targeted agents, HIPEC) reshaping outcomes in metastatic disease.
🔹 **Robotic surgery’s precision** in reducing morbidity while optimizing oncological resections—a game-changer in select patients.
🔹 The critical need for **multidisciplinary collaboration** between surgeons, oncologists, and palliative care teams.
Thrilling discussions with **senior physicians and surgeons** on real-world challenges:
• Can robotics bridge the gap between **open surgery and laparoscopy** in resource-limited settings?
• How do we integrate **emerging biomarkers** (like MSI-H/dMMR) into treatment algorithms?
• The cost vs. **long-term benefit** debate—is robotic adoption scalable in India?
Grateful for the vibrant exchange of ideas! As we push boundaries in **onco-surgery**, I’m reminded how innovation thrives when experts unite.